First Week of NEOG July 2026 Options Trading

Neogen Corp (NEOG) trades at $6.11; a $5.00 put is bid $0.45, which nets a $4.55 effective cost basis if sold-to-open and yields a 9.00% return (14.04% annualized) with a 73% probability of expiring worthless. On the call side, a $10.00 strike is bid $0.05; selling that covered call against shares purchased at $6.11 would cap upside at $10 but deliver a potential total return of 64.48% to July 2026 and a 0.82% immediate YieldBoost (1.28% annualized) with a 74% chance to expire worthless. Implied volatilities are elevated (put 72%, call 69%) with trailing 12-month volatility at 69%, underlining significant option premia and tradeable income strategies for investors willing to assume assignment risk.

Analysis

Market structure: The option market is signaling a preference for premium sellers — NEOG trades at $6.11 with July‑2026 $5 puts bid $0.45 (cost basis if assigned $4.55) and $10 calls bid $0.05. Implied vol (69–72%) roughly equals realized vol (69%), making carry trades (put selling, covered calls) attractive relative to buying options; probability quotes ~73%/74% of expiring worthless tilt odds to sellers. This benefits option writers and liquidity providers while pressuring buyers of tail protection.

Risk assessment: Tail risks include product recalls, contract losses or dilution — a single binary event could wipe out the premium and equity value (low-probability, high-impact). Immediate (days) risk is IV movement and execution; short/medium (weeks–months) risk is earnings or contract announcements; long term (quarters/years) depends on Neogen’s revenue growth and margin recovery. Hidden dependency: thin option liquidity and wide spreads can make theoretical probabilities stale; a >20 vol-point move would materially change P/L.

Trade implications: Primary high-expected-value plays are short premium structures sized small (1–2% portfolio). Sell-to-open July‑2026 $5 puts if comfortable owning at $4.55 (or use a $5/$3 put spread to cap tail) — prefer credit spreads to limit catastrophic assignment. If already long, sell $10 Jul‑2026 covered calls only if you accept capping upside to ~64% through expiry; otherwise avoid buying calls given rich IV.

Contrarian angle: Consensus leans toward simple yield collection but underestimates dilution/operational binary risk and option liquidity. The 73%/74% “expire worthless” odds underprice fat‑tail events in small caps; selling naked puts without hedge risks >30% move. Historical parallel: small-cap biotech/diagnostics frequently punish unhedged sellers around product/contract news — prefer defined‑risk sells and small sizing.

Key Decisions for Investors

• If willing to own NEOG, establish a sell-to-open July 2026 $5 put position (limit = $0.45) sized to 1–2% of portfolio cash; simultaneously place a protective buy $3 put (create $5/$3 put spread) to limit downside — target net credit ~ $0.25–$0.30, max risk per unit ~$1.75. Enter within 2 weeks; exit or adjust if IV drops >10 vol points or NEOG moves >20% intraday.
• If already long NEOG (~$6.11), sell-to-open July 2026 $10 covered calls at $0.05 for a 0.82% yield boost and cap upside to 64% to expiry; limit size to 1% portfolio and close if share price >$9 or IV compresses >15 vol points.
• Avoid buying long-dated calls/speculative upside due to IV ~70%; instead deploy defined-risk credit spreads (e.g., $5/$3 put spreads) or small iron-condors sized so max loss <2% portfolio. Prioritize trades with defined max loss and set automated adjustments for material news.
• Monitor these triggers over next 90 days: (1) quarterly earnings/contract announcements — close short premium 5 trading days before release; (2) any IV move >15–20 vol points — reduce exposure by 50%; (3) filings indicating equity raises/dilution — cut exposure to zero and unwind naked positions immediately.